Stock Price Quote

JAGADISHWAR PHARMACEUTICAL WORKS LTD.

NSE : NABSE : ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year :
Management Info
- Chairman - Managing Director
Registered Office

Address

Phone

Email

Website

Registrars Details
Listing :

NEWS

No News Found

Financials

in Millions
QTR ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  8509.00 (2.44%)
M.Cap ( in Cr)10952.11
RPG Life Sciences (BSE)
peergroup  1718.50 (4.75%)
M.Cap ( in Cr)2807.33
Astrazeneca Pharma I (BSE)
peergroup  6699.00 (1.12%)
M.Cap ( in Cr)16772.88
Pfizer (BSE)
peergroup  5005.70 (1.28%)
M.Cap ( in Cr)22893.31
Alembic Pharma (BSE)
peergroup  1035.50 (5.39%)
M.Cap ( in Cr)20246.00

Shareholding Pattern

PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
NON-INSTITUTION 0%

About Jagadishwar Pharmaceutical Works Ltd.

Jagadishwar Pharmaceutical Works Ltd. was incorporated in the year 1987. Its today's share price is 0. Its current market capitalisation stands at Rs 0 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Sonam Agarwal, Tulika Paul, Soma Ghosh, Sandip Kumar Singh, Gunodhar Ghosh, Swapan Sarkar.

It is listed on the BSE with a BSE Code of  , NSE with an NSE Symbol of and ISIN of . It's Registered office is at 205, Haribol Roy Market,A. T. Road,Near Saraf BuildingGuwahati-781001, Assam. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Prasanta Kumar Roy Barman, Rajesh U Shah & Associates, Shantimay Majumder & Co, SN Chakrabarty & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.